New hope for suicidal depression: online therapy plus ketamine shows promise in Rapid-Action trial
NCT ID NCT06480500
First seen Jan 02, 2026 · Last updated May 02, 2026 · Updated 17 times
Summary
This study tests whether adding intravenous ketamine to internet-based cognitive behavioural therapy (i-CBT) can quickly reduce suicidal thoughts and behaviors in people with treatment-resistant depression. About 110 adults will receive weekly i-CBT for 13 weeks, and half will also get six ketamine infusions over the first month. The goal is to see if the combination works faster and better than i-CBT alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Toronto General Hospital
RECRUITINGToronto, Ontario, Canada
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.